CanExport Innovation 2026: The Complete Guide to International R&D Partnership Funding

CanExport has become a household name among Canadian businesses chasing international markets — but most of that recognition belongs to its bigger sibling, CanExport SMEs. The smaller, quieter, and arguably more strategic member of the family is CanExport Innovation: a 75% cost-share program that pays for the legal, advisory, and travel costs of negotiating cross-border R&D and technology partnerships. It does not fund product launches. It does not fund marketing. It funds the conversations, contracts, and intellectual-property work that happen before a technology ever reaches a foreign market.

What CanExport Innovation is — and how it differs from CanExport SMEs

The two programs share a name, an administrator, and a basic philosophy of cost-shared support — and almost nothing else. They solve different problems, sit at different points of a company's international journey, and apply to different applicant types. Conflating them is the single most common reason CanExport Innovation applications get rejected on intake, because applicants describe market-entry activities instead of R&D-partnership activities.

The simplest test: if your activity is aimed at generating sales in a foreign market, you are looking at CanExport SMEs. If your activity is aimed at signing an R&D agreement with a foreign university, research institute, lab, or technology partner, you are looking at CanExport Innovation. There is no version of CanExport that funds both at the same time, and you cannot use Innovation funds to pay for activities that belong to SMEs (or vice versa). The program's audit teams check for exactly this kind of category drift, and a misaligned claim is the fastest path to a clawback.

The 75% cost-share and the $37.5K / $100K caps

CanExport Innovation reimburses up to 75% of eligible project costs, capped at $37,500 per project. To use the full $37,500, your eligible spend must reach approximately $50,000 — the other 25% (about $12,500) must come from the applicant's own resources, in cash. As with CanExport SMEs, in-kind contributions do not count. Salary time, donated office space, or volunteered legal advice cannot be used to satisfy the matching requirement.

The annual cap is calculated on a rolling 12-month basis from the date of your first approved project, not by calendar or fiscal year. That means a company that closes a $37,500 project in July 2026 cannot draw another full $37,500 until July 2027, but it can run two or three smaller concurrent projects so long as the aggregate stays within $100,000 over any rolling 12-month window. This nuance matters for organizations — particularly research centres — that pursue multiple foreign partnerships in parallel.

Eligible activities — what the money actually pays for

The eligible-cost categories under CanExport Innovation are intentionally narrow. The program is not designed to subsidize ongoing R&D or product development; it is designed to subsidize the discrete, often expensive activities required to find, qualify, and contractually engage a foreign research partner. Think of it as funding for the diligence and deal-making phase of an international R&D collaboration.

Two important nuances about the eligible-cost categories. First, they are strictly tied to a named foreign partner or set of prospective partners. Generic activities — "attend an industry conference," "improve our IP strategy," "explore Europe" — do not qualify. The application must identify the specific country, the specific partner organizations under consideration, and the specific R&D opportunity being pursued. Second, all eligible third-party costs (legal, advisory, market-intelligence) must be paid to arm's-length providers. Spouses, related parties, controlled entities, and consultants with pre-existing equity or commercial relationships to the applicant are excluded.

Ineligible activities — where CanExport Innovation explicitly will not go

The list of what CanExport Innovation does not fund is, in many ways, more instructive than the list of what it does. Because the program sits at the upstream end of the commercialization pipeline, anything that looks like production, sales, marketing, or operational R&D execution gets stripped from a claim. Practitioners should read this list before drafting any budget.

• The R&D work itself. Salaries, materials, lab costs, and other direct costs of conducting the research collaboration after the agreement is signed are not eligible. CanExport Innovation funds the path to the agreement, not the agreement's execution. For the R&D work itself, SR&ED and NSERC Alliance are the correct instruments.
• Production and manufacturing. Pilot-scale manufacturing, prototype fabrication for commercial use, tooling, capital equipment, and any production-related spend is excluded.
• Marketing and sales activities. Trade shows, advertising, lead generation, sales-focused collateral, website development, social media, and all activities targeted at generating revenue belong under CanExport SMEs, not Innovation.
• Distribution, licensing-only, and reseller agreements. If the proposed agreement is fundamentally a commercial channel relationship rather than a joint creation of new IP, the project is ineligible.
• Activities in markets or with partners not approved in the funding agreement. Same linking rule as CanExport SMEs — if it isn't in the approved file, it isn't eligible.
• Costs incurred before approval. Pre-application spend is permanently ineligible.
• Internal time. Employee salaries, founder time, in-kind labour, and overhead allocations cannot be claimed and cannot satisfy the 25% match.
• Canadian-domestic activity. Domestic travel, domestic IP filings, conferences inside Canada, and legal work that doesn't tie to a specific foreign-partner negotiation are excluded.
• Recoverable taxes. GST/HST and any refundable taxes are stripped from eligible costs.

Who can apply — SMEs vs academic institutions vs non-government research centres

CanExport Innovation is one of the few federal cost-shared programs that treats academic and corporate applicants as peers within the same envelope. This matters because the eligibility test, the assessment criteria, and the documentation requirements differ subtly across the three applicant categories.

For-profit Canadian SMEs

For-profit applicants must be Canadian-incorporated, with a valid CRA business number, operating in Canada, and demonstrably capable of delivering the proposed R&D collaboration. The SME revenue and headcount thresholds that govern CanExport SMEs do not apply identically here — CanExport Innovation is more accommodating of early-stage and pre-revenue technology companies, because the entire point of the program is to support partnership formation before commercial scale. Practical screening still applies: a company must be able to demonstrate that it has the technical depth, IP, and operational stability to be a credible counterparty to a foreign research partner. A two-person startup with no IP and no track record will struggle on assessment, even if it clears formal eligibility.

Academic institutions

Eligible academic institutions include Canadian universities, colleges, and degree-granting polytechnics. The applicant of record is usually the institution's research-services or industry-liaison office, not an individual professor. Academic applications should clearly link the proposed foreign collaboration to the institution's broader research strategy — centres of excellence, established faculty research programs, or existing federal granting council funding (NSERC, CIHR, SSHRC). The strongest academic files position CanExport Innovation as the bridge between a domestic NSERC-funded program and a future international Alliance International or Horizon Europe-style collaboration.

Non-government research centres

The third category includes independent, not-for-profit research organizations and applied-research centres — for example, sector-specific innovation hubs, contract research organizations operating as not-for-profits, and college-affiliated technology access centres. Federal Crown corporations and provincial government research bodies are typically excluded; the test is independence from direct government control. Non-government research centres usually compete well on CanExport Innovation because they are organizationally optimized for exactly this kind of partnership-brokering activity.

International partner requirements

The foreign partner is not a footnote — it is the entire premise of the application. CanExport Innovation expects the application to demonstrate four things about the proposed foreign partner relationship:

1. Specificity. Name the prospective partner or short list of partners. "A research institute in Germany" is not sufficient; "the Fraunhofer Institute for X, with whom we have had two introductory calls" is the level of specificity the program expects.
2. Substantive R&D content. The partnership must contemplate the joint creation of new technology, knowledge, or IP. A pure commercial relationship — licensing existing IP, distribution, or resale — does not qualify.
3. Mutuality of contribution. Each party must bring something material to the table: IP, technical capability, capital, market access, regulatory expertise, or facilities. A relationship where the Canadian party is purely a customer or purely a vendor does not meet the bar.
4. Foreseeable pathway to a formal agreement. The application should articulate how the proposed activities (travel, legal work, due diligence) lead to an MOU, joint development agreement, or collaboration agreement within a reasonable horizon — typically 12 to 24 months.

The country of the partner matters less than the substance, with one practical caveat: partnerships with entities in countries subject to Canadian sanctions, export controls, or national-security-related research-security advisories will face additional scrutiny. The federal government's research security guidelines — particularly those issued by ISED and the granting councils — apply to academic and research-centre applicants, and increasingly to private-sector applicants as well. Sensitive technology areas (quantum, AI, advanced materials, biotech, dual-use) attract closer review.

How to write a competitive application

The CanExport Innovation application form is shorter than the SMEs version, but the assessment is more substantive. Officers want to see a credible technical thesis, a specific partner relationship, and a defensible budget. The strongest applications share five characteristics.

Stacking CanExport Innovation with SR&ED

This is the most important strategic point in the article. CanExport Innovation funds the partnership-formation stage. SR&ED funds the underlying R&D itself. The two programs were designed to be complementary, and used together they can dramatically reduce the net cost of running an international R&D collaboration.

A practical sequence looks like this. The Canadian SME identifies a foreign research partner with complementary technology. CanExport Innovation reimburses 75% of the cost of the partnership-development work — the travel, legal opinions, IP analysis, and contract drafting — up to $37,500. Once the collaboration agreement is signed, the Canadian SME begins executing its portion of the joint R&D work in Canada. That work is SR&ED-eligible, provided it meets the standard CRA tests for scientific or technological uncertainty, hypothesis-driven experimentation, and systematic investigation under IC 2012-02. The Canadian R&D salaries, contract costs, and materials feed directly into the SR&ED claim for that fiscal year.

There is no stacking conflict between the two programs because they fund different cost categories. CanExport Innovation pays for partnership development; SR&ED reimburses qualifying R&D performed in Canada. Both can flow through the same project without breaching the federal 75% stacking ceiling on any individual cost, because no single cost is funded twice. What you cannot do is claim the same legal opinion or the same travel under both programs — each dollar of spend lands in exactly one bucket.

Stacking with NSERC Alliance for the underlying research

For academic and research-centre applicants, the natural downstream partner to CanExport Innovation is the NSERC Alliance International stream, which co-funds collaborative R&D projects between Canadian researchers and international partners. Alliance International grants cover the research work itself — researcher time, students and postdocs, materials, equipment — and require an established international partner. CanExport Innovation is, in a very real sense, the front-loading instrument that helps Canadian researchers find and qualify that international partner before submitting an Alliance application.

The full federated path for an academic applicant looks like: (1) use CanExport Innovation to fund the partnership-development phase — international travel, partner due diligence, IP scoping, MOU drafting; (2) co-author an Alliance International application with the now-identified foreign partner; (3) if successful, NSERC funds the joint research program over three to five years; (4) any commercializable IP that emerges feeds into a CanExport SMEs application (or a spin-out company's CanExport SMEs application) for market entry. This sequence converts a single $37,500 CanExport Innovation grant into a multi-year, multi-million-dollar federated research and commercialization pipeline. The institutions that get this sequence right are not necessarily the largest — they are the ones whose research-services offices treat the four programs as a single connected portfolio rather than as discrete one-off applications.

For-profit SMEs can follow an analogous federated path by combining CanExport Innovation with NRC IRAP (for early-stage joint-development scale-up), SR&ED (for the Canadian R&D execution), and CanExport SMEs (for downstream market entry once the technology is ready).

Common reasons applications fail

The reasons CanExport Innovation applications get rejected cluster into a small number of recurring patterns. Most are correctable with another draft.

• The activity is really market entry, not partnership formation. The most common failure mode. The applicant describes attending a trade show or hiring a sales consultant in a foreign market. This is a CanExport SMEs application wearing the wrong name tag.
• No identified partner. "We want to find a partner in Germany" is not a project. Without a named (or short-listed) prospective partner, the application has no specific R&D thesis and the budget cannot be tied to identifiable activities.
• The proposed agreement is licensing or distribution, not joint creation. An IP-licensing agreement does not meet the program's definition of collaborative R&D. Neither does a reseller arrangement or a manufacturing-for-hire contract.
• Costs that are really execution, not formation. Salary time for the Canadian researchers, materials for the joint project, equipment, lab time — all execution. CanExport Innovation will strip these from the budget at intake.
• Weak technical credibility. The application doesn't establish that the Canadian applicant has the technical depth, IP, or capacity to be a serious R&D counterparty. Officers will not fund partnership-formation activity for organizations that cannot deliver the underlying R&D.
• Inflated or unjustified budget. $15,000 for a single freedom-to-operate opinion, or $12,000 for a one-week trip, will be flagged and reduced. Use realistic, quotable market rates and keep documentation.
• Research-security flags. Partnerships involving sensitive technology areas or partners in countries flagged under federal research-security guidance face slower assessment and a higher rejection rate. Be aware of the guidelines that apply to your sector before submitting.
• Pre-application spend. The applicant has already started the activity. Costs incurred before the funding agreement is signed are not eligible — full stop — and including them signals an unfamiliarity with the program rules that reviewers notice.

Final thoughts

CanExport Innovation is one of the most surgically useful federal programs available to Canadian innovators — precisely because it does one thing and does it well. It pays for the unglamorous, deal-room work that international R&D partnerships require before any technology ever crosses a border. For founders and research administrators who treat partnership formation as a strategic discipline rather than a side activity, the 75% cost share can change the economics of pursuing the right foreign collaborator instead of the easy one.

The program rewards organizations that come to the application with a real partner, a real R&D thesis, and a real plan for what happens after the signature. It penalizes organizations that treat it as a generic travel-and-legal grant, or that confuse it with the market-entry function of CanExport SMEs. The difference between an approved and a rejected file is rarely the technology — it is whether the applicant has internalized that CanExport Innovation funds the deal, not the work that follows the deal.

For SMEs, the highest-leverage move is to think of CanExport Innovation as a coupon on the front end of an SR&ED-eligible Canadian R&D programme that happens to have an international partner attached. For academic institutions and research centres, it is the bridge between domestic NSERC funding and Alliance International or Horizon Europe-scale collaborations. In both cases, the program is most valuable when used as one node in a connected federal funding stack — not as a standalone grant.

CanExport Innovation is one of several Canadian innovation and export programs. Use our Grant Finder to compare it against CanExport SMEs, NRC IRAP, NSERC Alliance, and SR&ED before committing application time.